Table 4 Management and outcomes of Covid-19 patients according to sex and DM status
Parameters (%) | Males | Females | p-value | Non-DM | DM | p-value |
|---|---|---|---|---|---|---|
N | 300 | 139 | 139 | 300 | ||
On admission | Â | Â | NS | Â | Â | NS |
 Ward | 242 (80.7) | 118 (84.9) |  | 118 (84.9) | 242 (80.7) |  |
ICU | 58 (19.3) | 21 (15.1) | Â | 21 (15.1) | 58 (19.3) | Â |
Required O2 on arrival to ER | 124 (41.3) | 54 (38.8) | NS | 43 (30.9) | 135 (45.0) | 0.006 |
Antiviral | 10 (3.3) | 8 (5.8) | NS | 9 (6.5) | 9 (3.0) | NS |
Tocilizumab | 19 (6.3) | 6 (4.3) | NS | 4 (2.9) | 21 (7.0) | NS |
Hydroxychloroquine | 4 (1.3) | 4 (2.9) | NS | 5 (3.6) | 3 (1.0) | NS |
 Antibiotics | 272 (90.7) | 117 (84.2) | 0.05 | 106 (76.3) | 283 (94.3) | < 0.001 |
 Dexamethasone | 164 (54.7) | 69 (50.0) | NS | 50 (36.2) | 183 (61.0) | < 0.001 |
 Required Intubation | 54 (18.2) | 23 (16.5) | NS | 17 (12.3) | 60 (20.3) | 0.04 |
 Transferred to ICU | 82 (27.3) | 41 (29.7) | NS | 32 (23.4) | 91 (30.5) | NS |
Outcome | ||||||
 Mortality | 55 (18.6) | 22 (16.3) | NS | 17 (12.3) | 60 (20.5) | 0.04 |
 Discharged/Recovered | 234 (79.9) | 109 (81.3) | NS | 118 (86.1) | 225 (77.6) | NS |
Time lapse from diagnosis [median number of days (min–max)] | ||||||
 Admission | 1 (1–37) | 1 (1–32) | NS | 1 (1–19) | 1 (1–37) | NS |
 Intubation | 1 (1–23) | 1 (1–19) | NS | 1 (1–20) | 1 (1–23) | NS |
 ICU admission | 2 (1–20) | 3 (1–16) | NS | 3.0 (1–16) | 3 (1–20) | NS |
 Discharge | 10 (1–50) | 11 (1–50) | NS | 10 (2–50) | 10 (1–50) | NS |
 Mortality | 13.5 (1–47) | 11 (1–29) | NS | 15 (1–28) | 12 (1–47) | NS |